Literature DB >> 34980240

Autism screening at 18 months of age: a comparison of the Q-CHAT-10 and M-CHAT screeners.

Raymond Sturner1,2, Barbara Howard3,4, Paul Bergmann4,5, Shana Attar4,6, Lydia Stewart-Artz7, Kerry Bet7,4, Carrie Allison8, Simon Baron-Cohen8.   

Abstract

BACKGROUND: Autism screening is recommended at 18- and 24-month pediatric well visits. The Modified Checklist for Autism in Toddlers-Revised (M-CHAT-R) authors recommend a follow-up interview (M-CHAT-R/F) when positive. M-CHAT-R/F may be less accurate for 18-month-olds than 24-month-olds and accuracy for identification prior to two years is not known in samples that include children screening negative. Since autism symptoms may emerge gradually, ordinally scoring items based on the full range of response options, such as in the 10-item version of the Quantitative Checklist for Autism in Toddlers (Q-CHAT-10), might better capture autism signs than the dichotomous (i.e., yes/no) items in M-CHAT-R or the pass/fail scoring of Q-CHAT-10 items. The aims of this study were to determine and compare the accuracy of the M-CHAT-R/F and the Q-CHAT-10 and to describe the accuracy of the ordinally scored Q-CHAT-10 (Q-CHAT-10-O) for predicting autism in a sample of children who were screened at 18 months.
METHODS: This is a community pediatrics validation study with screen positive (n = 167) and age- and practice-matched screen negative children (n = 241) recruited for diagnostic evaluations completed prior to 2 years old. Clinical diagnosis of autism was based on results of in-person diagnostic autism evaluations by research reliable testers blind to screening results and using the Autism Diagnostic Observation Schedule-Second Edition (ADOS-2) Toddler Module and Mullen Scales of Early Learning (MSEL) per standard guidelines.
RESULTS: While the M-CHAT-R/F had higher specificity and PPV compared to M-CHAT-R, Q-CHAT-10-O showed higher sensitivity than M-CHAT-R/F and Q-CHAT-10. LIMITATIONS: Many parents declined participation and the sample is over-represented by higher educated parents. Results cannot be extended to older ages.
CONCLUSIONS: Limitations of the currently recommended two-stage M-CHAT-R/F at the 18-month visit include low sensitivity with minimal balancing benefit of improved PPV from the follow-up interview. Ordinal, rather than dichotomous, scoring of autism screening items appears to be beneficial at this age. The Q-CHAT-10-O with ordinal scoring shows advantages to M-CHAT-R/F with half the number of items, no requirement for a follow-up interview, and improved sensitivity. Yet, Q-CHAT-10-O sensitivity is less than M-CHAT-R (without follow-up) and specificity is less than the two-stage procedure. Such limitations are consistent with recognition that screening needs to recur beyond this age.
© 2021. The Author(s).

Entities:  

Keywords:  Autism screening; Developmental screening; M-CHAT; Q-CHAT

Mesh:

Year:  2022        PMID: 34980240      PMCID: PMC8722322          DOI: 10.1186/s13229-021-00480-4

Source DB:  PubMed          Journal:  Mol Autism            Impact factor:   7.509


  38 in total

Review 1.  The screening and diagnosis of autistic spectrum disorders.

Authors:  P A Filipek; P J Accardo; G T Baranek; E H Cook; G Dawson; B Gordon; J S Gravel; C P Johnson; R J Kallen; S E Levy; N J Minshew; S Ozonoff; B M Prizant; I Rapin; S J Rogers; W L Stone; S Teplin; R F Tuchman; F R Volkmar
Journal:  J Autism Dev Disord       Date:  1999-12

2.  Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples.

Authors:  Enrique F Schisterman; Neil J Perkins; Aiyi Liu; Howard Bondell
Journal:  Epidemiology       Date:  2005-01       Impact factor: 4.822

3.  Index for rating diagnostic tests.

Authors:  W J YOUDEN
Journal:  Cancer       Date:  1950-01       Impact factor: 6.860

4.  The diagnosis of autism in community pediatric settings: does advanced training facilitate practice change?

Authors:  Amy R Swanson; Zachary E Warren; Wendy L Stone; Alison C Vehorn; Elizabeth Dohrmann; Quentin Humberd
Journal:  Autism       Date:  2013-07-11

5.  Accuracy of Autism Screening in a Large Pediatric Network.

Authors:  Whitney Guthrie; Kate Wallis; Amanda Bennett; Elizabeth Brooks; Jesse Dudley; Marsha Gerdes; Juhi Pandey; Susan E Levy; Robert T Schultz; Judith S Miller
Journal:  Pediatrics       Date:  2019-10       Impact factor: 7.124

6.  Autism Screening With Online Decision Support by Primary Care Pediatricians Aided by M-CHAT/F.

Authors:  Raymond Sturner; Barbara Howard; Paul Bergmann; Tanya Morrel; Lindsay Andon; Danielle Marks; Patricia Rao; Rebecca Landa
Journal:  Pediatrics       Date:  2016-08-19       Impact factor: 7.124

7.  The Modified Checklist for Autism in Toddlers: an initial study investigating the early detection of autism and pervasive developmental disorders.

Authors:  D L Robins; D Fein; M L Barton; J A Green
Journal:  J Autism Dev Disord       Date:  2001-04

Review 8.  A systematic review of early intensive intervention for autism spectrum disorders.

Authors:  Zachary Warren; Melissa L McPheeters; Nila Sathe; Jennifer H Foss-Feig; Allison Glasser; Jeremy Veenstra-Vanderweele
Journal:  Pediatrics       Date:  2011-04-04       Impact factor: 7.124

9.  Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model.

Authors:  Geraldine Dawson; Sally Rogers; Jeffrey Munson; Milani Smith; Jamie Winter; Jessica Greenson; Amy Donaldson; Jennifer Varley
Journal:  Pediatrics       Date:  2009-11-30       Impact factor: 7.124

10.  The Q-CHAT (Quantitative CHecklist for Autism in Toddlers): a normally distributed quantitative measure of autistic traits at 18-24 months of age: preliminary report.

Authors:  Carrie Allison; Simon Baron-Cohen; Sally Wheelwright; Tony Charman; Jennifer Richler; Greg Pasco; Carol Brayne
Journal:  J Autism Dev Disord       Date:  2008-02-01
View more
  1 in total

1.  Do Autism-Specific and General Developmental Screens Have Complementary Clinical Value?

Authors:  Raymond Sturner; Paul Bergmann; Barbara Howard; Kerry Bet; Lydia Stewart-Artz; Shana Attar
Journal:  J Autism Dev Disord       Date:  2022-05-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.